The introduction of the 750mcg teriparatide solution in Australia has seen limited distribution to date. Primarily reserved for patients with severe bone loss who have not responded to other therapies , access is strictly managed. Present supply levels are tight , and sufferers should verify from their specialist the latest information on obtain… Read More